FDA Crackdown: Influencer Health Claims Risk Brand Ruin
Learn FDA and FTC rules on influencer health claims in viral ads: what statements are allowed, substantiation required, risk disclosures needed, and compliance steps to avoid warnings.
Learn FDA and FTC rules on influencer health claims in viral ads: what statements are allowed, substantiation required, risk disclosures needed, and compliance steps to avoid warnings.
This article unpacks the regulatory framework implicated by the Hims & Hers’ Super Bowl advertisement, explores the implications for the company and the broader pharmaceutical and telehealth industries, and discusses how evolving enforcement trends may shape future drug promotion practices.
The FDA’s announcement, published in the Federal Register, highlights the “novel risks” posed by devices having Mental Health Chatbots and signals a shift toward more stringent oversight to ensure safety and efficacy. This article explores the implications of these regulatory developments, the evolving landscape, and what it means for companies and users alike.